Alverix, Inc., a world leader in the design and manufacture of next-generation platforms for diagnostic Point-of-Care (POC) testing, announced today that BD Diagnostics, a segment of Becton Dickinson and Company (NYSE:BDX), a leading global medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD VeritorTM System for Rapid Detection of Flu A + B. This new product is cleared for use in clinical settings.
BD selected Alverix to design, develop and supply the digital reader component of BD’s new POC diagnostic system, which offers users advanced performance with reliable, easy-to-read results. The new BD Veritor System for Rapid Detection of Flu A + B laboratory kit is specifically configured for testing liquid specimens obtained via nasopharyngeal wash, aspirate or swab in transport media. The system, with proprietary technologies, eliminates the subjective result interpretation of visually read assays and helps deliver an accurate read by providing reliable, objective results on a hand-held digital reader designed, developed and manufactured by Alverix, Inc. The BD Veritor System for Rapid Detection of Flu A + B demonstrated proven performance versus polymerase chain reaction (PCR) tests. This is the first rapid diagnostic flu test that has been referenced and FDA-cleared against this high-sensitivity standard.
“The clearance of the new BD Veritor System kit specifically for samples in transport media in clinical settings is a significant addition to the Flu A + B product line,” said Ric Tarbox, CEO of Alverix. “The BD Veritor System can now provide accuracy, consistency and convenience to all near patient testing environments allowing integrated delivery networks to realize all of the cost saving synergies normally associated with standardization of product and testing procedures. Alverix is truly excited to be associated with BD in delivering rapid results that physicians and laboratory professionals can trust.”
The BD Veritor System utilizes Advanced Particle and Adaptive Read technologies that are integrated into a proprietary hand-held digital reader from Alverix, Inc. The Advanced Particle Technology, along with improved chemistries, greatly increases the sensitivity of the test. The Adaptive Read technology reduces false-positive results through analyzing and compensating for many of the effects of non-specific binding resulting in improved specificity.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV